Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sabbagh

Showing results (241-250 of 330) with videos related to

Pageof 33
Sort By:
Biomarker Insights|March 28, 2013
Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathologyChera L Maarouf, Thomas G Beach, Charles H Adler, et al.
Neurology|July 1, 2014
Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic studyCharles H Adler, Thomas G Beach, Joseph G Hentz, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 27, 2009
Patients with Alzheimer disease have altered transmitral flow: echocardiographic analysis of the vortex formation timeMarek Belohlavek, Panupong Jiamsripong, Anna M Calleja, et al.
Alzheimer'S Research & Therapy|July 10, 2024
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's diseaseLawrence S Honig, Marwan N Sabbagh, Christopher H van Dyck, et al.
Acta Neuropathologica|November 7, 2007
Reduced striatal tyrosine hydroxylase in incidental Lewy body diseaseThomas Gerald Beach, Charles H Adler, Lucia I Sue, et al.
Neuroscience|February 4, 2021
Examining the Role of Microbiota in Emotional Behavior: Antibiotic Treatment Exacerbates Anxiety in High Anxiety-Prone Male RatsM E Glover, J L Cohen, J R Singer, et al.
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
Early Detection of Mild Cognitive Impairment (MCI) in an At-Home SettingM N Sabbagh, M Boada, S Borson, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2018
Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension StudyStephen P Salloway, Reisa Sperling, Nick C Fox, et al.
Acta Neuropathologica|November 5, 2008
Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disordersThomas G Beach, Charles L White, Christa L Hladik, et al.
Alzheimer'S Research & Therapy|May 10, 2024
Updated safety results from phase 3 lecanemab study in early Alzheimer's diseaseLawrence S Honig, Marwan N Sabbagh, Christopher H van Dyck, et al.
Pageof 33

Showing results (241-250 of 330) with videos related to

Sort By:
Pageof 33
Biomarker Insights|March 28, 2013
Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathologyChera L Maarouf, Thomas G Beach, Charles H Adler, et al.
Neurology|July 1, 2014
Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic studyCharles H Adler, Thomas G Beach, Joseph G Hentz, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 27, 2009
Patients with Alzheimer disease have altered transmitral flow: echocardiographic analysis of the vortex formation timeMarek Belohlavek, Panupong Jiamsripong, Anna M Calleja, et al.
Alzheimer'S Research & Therapy|July 10, 2024
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's diseaseLawrence S Honig, Marwan N Sabbagh, Christopher H van Dyck, et al.
Acta Neuropathologica|November 7, 2007
Reduced striatal tyrosine hydroxylase in incidental Lewy body diseaseThomas Gerald Beach, Charles H Adler, Lucia I Sue, et al.
Neuroscience|February 4, 2021
Examining the Role of Microbiota in Emotional Behavior: Antibiotic Treatment Exacerbates Anxiety in High Anxiety-Prone Male RatsM E Glover, J L Cohen, J R Singer, et al.
The Journal of Prevention of Alzheimer'S Disease|May 29, 2020
Early Detection of Mild Cognitive Impairment (MCI) in an At-Home SettingM N Sabbagh, M Boada, S Borson, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2018
Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension StudyStephen P Salloway, Reisa Sperling, Nick C Fox, et al.
Acta Neuropathologica|November 5, 2008
Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disordersThomas G Beach, Charles L White, Christa L Hladik, et al.
Alzheimer'S Research & Therapy|May 10, 2024
Updated safety results from phase 3 lecanemab study in early Alzheimer's diseaseLawrence S Honig, Marwan N Sabbagh, Christopher H van Dyck, et al.
Pageof 33